Dyne Therapeutics (NASDAQ:DYN) Coverage Initiated at Royal Bank of Canada
Analysts at Royal Bank of Canada assumed coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a report ...
Dyne Therapeutics initiated with an Outperform at RBC Capital
RBC Capital analyst Luca Issi initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $45 price target. Dyne’s lead program ...
COP29 ends with empty deal, as 2024 set to be warmest year on human record
According to the Copernicus Climate Change Service, “The average temperature anomaly for the rest of 2024 would have to drop ...